Published in Aliment Pharmacol Ther on February 15, 2005
Randomised clinical trial: safety, tolerability, pharmacokinetics and pharmacodynamics of repeated doses of TAK-438 (vonoprazan), a novel potassium-competitive acid blocker, in healthy male subjects. Aliment Pharmacol Ther (2015) 1.18
Randomised clinical trial: a dose-ranging study of vonoprazan, a novel potassium-competitive acid blocker, vs. lansoprazole for the treatment of erosive oesophagitis. Aliment Pharmacol Ther (2015) 1.04
A review of esomeprazole in the treatment of gastroesophageal reflux disease (GERD). Ther Clin Risk Manag (2007) 0.94
Effect of timing of dosing in relation to food intake on the pharmacokinetics of esomeprazole. Br J Clin Pharmacol (2007) 0.85
Delayed release dexlansoprazole in the treatment of GERD and erosive esophagitis. Clin Exp Gastroenterol (2009) 0.83
Recent effectiveness of proton pump inhibitors for severe reflux esophagitis: the first multicenter prospective study in Japan. J Clin Biochem Nutr (2015) 0.83
Esomeprazole for the treatment of erosive esophagitis in children: an international, multicenter, randomized, parallel-group, double-blind (for dose) study. BMC Pediatr (2010) 0.82
A multicenter, randomized, double-blind, 8-week comparative trial of standard doses of esomeprazole (40 mg) and omeprazole (20 mg) for the treatment of erosive esophagitis. Dig Dis Sci (2006) 0.81
Heartburn severity does not predict disease severity in patients with erosive esophagitis. MedGenMed (2006) 0.79
The value of branded proton pump inhibitors: formulary considerations. P T (2011) 0.78
Proton pump inhibitor step-down therapy for GERD: a multi-center study in Japan. World J Gastroenterol (2011) 0.77
Managing peptic ulcer and gastroesophageal reflux disease in elderly Chinese patients--focus on esomeprazole. Clin Interv Aging (2013) 0.76
Management of gastroesophageal reflux disease and erosive esophagitis in pediatric patients: focus on delayed-release esomeprazole. Ther Clin Risk Manag (2010) 0.75
Patient acceptability and experiences of therapeutic switching of proton pump inhibitors within the National Preferred Drugs initiative in Ireland. Ir J Med Sci (2016) 0.75
Comparative effectiveness and acceptability of the FDA-licensed proton pump inhibitors for erosive esophagitis: A PRISMA-compliant network meta-analysis. Medicine (Baltimore) (2017) 0.75
Co-ordinate regulation of Salmonella typhimurium invasion genes by environmental and regulatory factors is mediated by control of hilA expression. Mol Microbiol (1996) 3.94
hilA is a novel ompR/toxR family member that activates the expression of Salmonella typhimurium invasion genes. Mol Microbiol (1995) 3.73
Colonoscopy in rural family practice. Tenn Med (1998) 2.17
Clinical trial: lubiprostone in patients with constipation-associated irritable bowel syndrome--results of two randomized, placebo-controlled studies. Aliment Pharmacol Ther (2008) 2.06
Quasiperiodicity and chaos in cardiac fibrillation. J Clin Invest (1997) 1.99
Use of the Web for medical information by a gastroenterology clinic population. JAMA (2000) 1.97
Recombinant vaccinia-PSA (PROSTVAC) can induce a prostate-specific immune response in androgen-modulated human prostate cancer. Urology (1999) 1.92
Isolation and genetic analysis of mutant strains of Chlamydomonas reinhardi defective in gametic differentiation. Genetics (1976) 1.90
Safety and patient outcomes with lubiprostone for up to 52 weeks in patients with irritable bowel syndrome with constipation. Aliment Pharmacol Ther (2012) 1.83
Efficacy and safety of esomeprazole compared with omeprazole in GERD patients with erosive esophagitis: a randomized controlled trial. Am J Gastroenterol (2001) 1.67
Clinical trial: the incidence of NSAID-associated endoscopic gastric ulcers in patients treated with PN 400 (naproxen plus esomeprazole magnesium) vs. enteric-coated naproxen alone. Aliment Pharmacol Ther (2010) 1.66
Identification and visualization of the sexual agglutinin from the mating-type plus flagellar membrane of Chlamydomonas. Cell (1983) 1.61
Clinical trial: the efficacy and tolerability of velusetrag, a selective 5-HT4 agonist with high intrinsic activity, in chronic idiopathic constipation - a 4-week, randomized, double-blind, placebo-controlled, dose-response study. Aliment Pharmacol Ther (2010) 1.56
Characteristics of wave fronts during ventricular fibrillation in human hearts with dilated cardiomyopathy: role of increased fibrosis in the generation of reentry. J Am Coll Cardiol (1998) 1.52
Sex-limited expression of gene Loci controlling flagellar membrane agglutination in the chlamydomonas mating reaction. Genetics (1978) 1.46
Relation between ligament of Marshall and adrenergic atrial tachyarrhythmia. Circulation (1999) 1.45
Activation for cell fusion in Chlamydomonas: analysis of wild-type gametes and nonfusing mutants. J Cell Biol (1982) 1.44
Sexual agglutinins from the Chlamydomonas flagellar membrane. Partial purification and characterization. J Biol Chem (1982) 1.42
An improved approach to delivery of enteral nutrition in the intensive care unit. Gastrointest Endosc (1995) 1.40
The ligament of Marshall: a structural analysis in human hearts with implications for atrial arrhythmias. J Am Coll Cardiol (2000) 1.40
Outcomes of acute esophageal food impaction: success of the push technique. Gastrointest Endosc (2001) 1.26
Meta-analysis of flavonoids for the treatment of haemorrhoids. Br J Surg (2006) 1.26
Risk factors for the severity of erosive esophagitis in Helicobacter pylori-negative patients with gastroesophageal reflux disease. Scand J Gastroenterol (2002) 1.25
A national population-based study of incidence of colorectal cancer and age. Implications for screening in older Americans. Cancer (1995) 1.12
Endoscopic therapy in patients with pancreas divisum and acute pancreatitis: a prospective, randomized, controlled clinical trial. Gastrointest Endosc (1992) 1.12
Reentrant wave fronts in Wiggers' stage II ventricular fibrillation. Characteristics and mechanisms of termination and spontaneous regeneration. Circ Res (1996) 1.11
Genetic and environmental influences on echocardiographically determined left ventricular mass in black twins. Am J Hypertens (1990) 1.08
Laxatives for the treatment of hemorrhoids. Cochrane Database Syst Rev (2005) 1.05
Wolff-Parkinson-White syndrome in a cardiac allograft. Ann Thorac Surg (1995) 1.03
The new proton pump inhibitor esomeprazole is effective as a maintenance therapy in GERD patients with healed erosive oesophagitis: a 6-month, randomized, double-blind, placebo-controlled study of efficacy and safety. Aliment Pharmacol Ther (2001) 1.03
Randomised clinical trial: the long-term safety and tolerability of naloxegol in patients with pain and opioid-induced constipation. Aliment Pharmacol Ther (2014) 0.99
Life-threatening alterations in heart rate after the use of adenosine in atrial flutter. Am Heart J (1995) 0.99
Optimal timing for stent replacement in malignant biliary tract obstruction. Gastrointest Endosc (1993) 0.98
Mxi1, a Myc antagonist, suppresses proliferation of DU145 human prostate cells. Prostate (2001) 0.98
Clinical trial: esomeprazole for moderate-to-severe nighttime heartburn and gastro-oesophageal reflux disease-related sleep disturbances. Aliment Pharmacol Ther (2010) 0.94
Evaluation of post-ERCP pancreatitis: potential causes noted during controlled study of differing contrast media. Midwest Pancreaticobiliary Study Group. Gastrointest Endosc (1997) 0.90
Controlled evaluation of copper-silver ionization in eradicating Legionella pneumophila from a hospital water distribution system. J Infect Dis (1994) 0.88
The Shc 66 and 46 kD isoforms are differentially downregulated at parturition in the fetal mouse lung. Pediatr Res (1998) 0.88
Interaction between strong electrical stimulation and reentrant wavefronts in canine ventricular fibrillation. Circ Res (1995) 0.88
Effect of capacitor size and pathway resistance on defibrillation threshold for implantable defibrillators. Circulation (1994) 0.88
Clinical trial: healing of NSAID-associated gastric ulcers in patients continuing NSAID therapy - a randomized study comparing ranitidine with esomeprazole. Aliment Pharmacol Ther (2007) 0.88
An experimental validation of mathematical simulation of human thermoregulation. Comput Biol Med (1977) 0.86
Induction of tumor antigen-specific immunity in vivo by a novel vaccinia vector encoding safety-modified simian virus 40 T antigen. J Natl Cancer Inst (1999) 0.84
Focus of signet ring cell carcinoma in an adenoma of the sigmoid colon. Arch Pathol Lab Med (1999) 0.84
Safety and efficacy of long term esomeprazole therapy in patients with healed erosive oesophagitis. Drug Saf (2001) 0.82
Circadian variation of blood pressure in blacks: influence of age, gender and activity. J Hum Hypertens (1990) 0.82
Optimal electrode configuration for pectoral transvenous implantable defibrillator without an active can. Am J Cardiol (1995) 0.82
Current concepts of ventricular defibrillation. J Cardiovasc Electrophysiol (1998) 0.81
Measurement and control of dissolved carbon dioxide in mammalian cell culture processes using an in situ fiber optic chemical sensor. Biotechnol Prog (2000) 0.80
Age-related differences in the spontaneous and thyrotropin-releasing hormone-stimulated release of prolactin and thyrotropin in ovariectomized rats. Neuroendocrinology (1989) 0.80
Ablation of postinfarction ventricular tachycardia guided by isolated diastolic potentials. Europace (2003) 0.80
Effects of voltage and respiration on impedance in nonthoracotomy defibrillation pathways. Am J Cardiol (1994) 0.79
Clinical trial: evaluation of gastric acid suppression with three doses of immediate-release esomeprazole in the fixed-dose combination of PN 400 (naproxen/esomeprazole magnesium) compared with naproxen 500 mg and enteric-coated esomeprazole 20 mg: a randomized, open-label, Phase I study in healthy volunteers. Aliment Pharmacol Ther (2010) 0.79
Radiofrequency ablation of focal atrial tachycardia and atrioatrial conduction from recipient to donor after orthotopic heart transplantation. J Cardiovasc Electrophysiol (2000) 0.79
Underdetection of ventricular tachycardia by algorithms to enhance specificity in a tiered-therapy cardioverter-defibrillator. J Am Coll Cardiol (1994) 0.78
TGF-beta isoforms differentially attenuate EGF mitogenicity and receptor activity in fetal lung mesenchymal cells. Am J Physiol (1997) 0.78
Age-related differences in gastric acid secretion and response of gastric inhibitory polypeptide after oral glucose in male rats. Chin J Physiol (1993) 0.78
Eosinophilic ascites without eosinophilia: a unique presentation of serosal eosinophilic gastroenteritis. Am J Gastroenterol (1993) 0.78
Comparison of two strategies for intensifying antihypertensive treatment: low-dose combination (enalapril + felodipine ER) versus increased dose of monotherapy (enalapril). LEVEL (Lexxel vs Enalapril) Study Group. Am J Hypertens (1999) 0.78
Controlling the nanoscale rippling of graphene with SiO2 nanoparticles. Nanoscale (2014) 0.78
Induction of meandering functional reentrant wave front in isolated human atrial tissues. Circulation (1997) 0.78
Programming of implantable cardioverter-defibrillators on the basis of the upper limit of vulnerability. Circulation (1997) 0.78
Measurement of the soluble membrane receptors for tumor necrosis factor and lymphotoxin in the sera of patients with gynecologic malignancy. Gynecol Oncol (1993) 0.77
Regulation of thyroid hormones in the secretion of insulin and gastric inhibitory polypeptide in male rats. Metabolism (1997) 0.77
Short biphasic pulses from 90 microfarad capacitors lower defibrillation threshold. Pacing Clin Electrophysiol (1996) 0.77
The structure and properties of graphene on gold nanoparticles. Nanoscale (2015) 0.76
Support vector machine quantile regression for detecting differentially expressed genes in microarray analysis. Methods Inf Med (2008) 0.75
Healing rates for moderate and severe oesophagitis. Aliment Pharmacol Ther (2006) 0.75
Colonoscopy in rural family practice--rebuttal to response. Tenn Med (1999) 0.75
Focal source hypothesis of atrial fibrillation. J Electrocardiol (1998) 0.75
To scope or not to scope: the role of endoscopy in the evaluation of AIDS-related diarrhea. Am J Gastroenterol (1996) 0.75
Personal cooling with dry ice. Am Ind Hyg Assoc J (1974) 0.75
Comparison of the effects of intravenously and orally administered esomeprazole on acid output in patients with symptoms of gastro-oesophageal reflux disease. Aliment Pharmacol Ther (2005) 0.75
Upper limit of vulnerability predicts chronic defibrillation threshold for transvenous implantable defibrillators. J Cardiovasc Electrophysiol (1997) 0.75
A validation study of the Del Mar Avionics Pressurometer IV according to AAMI guidelines. J Hypertens (1988) 0.75
Randomized, placebo-controlled single-ascending-dose study to evaluate the safety, tolerability and pharmacokinetics of the HIV nucleoside reverse transcriptase inhibitor, BMS-986001, in healthy subjects. J Clin Pharmacol (2014) 0.75
A case of unilateral scrotal calcinosis. Clin Exp Dermatol (2009) 0.75
US double-blind, controlled trials of omeprazole and amoxycillin for treatment of Helicobacter pylori. Aliment Pharmacol Ther (1998) 0.75
Kallikrein content of rat pancreatic acinar cells or islets by direct radioimmunoassay. Hoppe Seylers Z Physiol Chem (1980) 0.75
Development of Eddy Current Sensor systems in artificial heart for noncontact gap sensing. Conf Proc IEEE Eng Med Biol Soc (2005) 0.75